Universität Duisburg-Essen (UDE)

University / College


Location: Duisburg, Essen, Germany (DE) DE

ISNI: 0000000121875445

ROR: https://ror.org/04mz5ra38

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Fractal Substructure of a nanopowder generated by repeated fragmentation and sedimentation: The role of the dust (2016) Topic N, Wolf DE, Pöschel T Journal article, Original article Thermoelectric properties of Ge/Si heterostructures: A combined theoretical and experimental study (2016) Fiedler G, Nausner L, Hu Y, Chen P, Rastelli A, Kratzer P Journal article Towards Deriving Programming Competencies from Student Errors (2016) Berges MP, Striewe M, Shah P, Goedicke M, Hubwieser P Conference contribution, Conference Contribution COMBINED ALTERATIONS IN MAPK PATHWAY GENES, CDKN2A/B AND ATRX CHARACTERIZE ANAPLASTIC PILOCYTIC ASTROCYTOMA (2016) Kratz A, Sahm F, Schrimpf D, Jones DT, Reuss D, Koelsche C, Huang K, et al. Conference contribution The total variation flow with time dependent boundary values (2016) Bögelein V, Duzaar F, Scheven C Journal article The obstacle problem for the total variation flow (2016) Bögelein V, Duzaar F, Scheven C Journal article Growth in thyroid disorders in childhood and adolescence. Thyroid dysfunction and growth (2016) Bettendorf M, Binder G, Hauffa BP, Pohlenz J, Rohrer TR, Schöfl C, Dörr HG Journal article Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease (2016) Siegel S, Milian M, Kleist B, Psaras T, Tsiogka M, Fuehrer D, Koltowska-Haggstrom M, et al. Journal article Decreased IL-10(+) regulatory B cells (Bregs) in lupus nephritis patients (2016) Heinemann K, Wilde B, Hoerning A, Tebbe B, Kribben A, Witzke O, Dolff S Journal article Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial (2016) Eigentler TK, Gutzmer R, Hauschild A, Heinzerling L, Schadendorf D, Nashan D, Hoelzle E, et al. Journal article